150th implant, page-4

the conclusions to draw would be that htw has had only one death in their pilot trial and the device is smaller and more easily tolerated and implanted.
Htw shareholder communications are more transparent and superior to vcr.
Shareholder sentiment at an all time low for vcr.
Vcr posted a huge loss.
How many did they sell in Europe anyway?
SP for VCR 20% below recent placement.
SP for HTW above recent placement.
Htw seems to have a pipeline of smaller innovative products.
Htw is catching up. CE mark coming soon. US trials commencing soon.
Chart movements following similar patterns over last 6 months. Wonder if that's about to change...